Funding Briefs

Kresge Works To Rebuild Labs Seattle University will renovate its chemistry labs; the University of Notre Dame is fixing up its Center for Biotechnology and Pollution Control; and Clark University in Worcester, Mass., will get new equipment for its Consortium Nuclear Magnetic Resonance Facility. These schools are three of 15 institutions to receive Kresge Foundation Science Initiative Grants. The two-year program provided $5 million in 1989 and will provide $5 million in 1990 to nonprofit inst

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Seattle University will renovate its chemistry labs; the University of Notre Dame is fixing up its Center for Biotechnology and Pollution Control; and Clark University in Worcester, Mass., will get new equipment for its Consortium Nuclear Magnetic Resonance Facility. These schools are three of 15 institutions to receive Kresge Foundation Science Initiative Grants. The two-year program provided $5 million in 1989 and will provide $5 million in 1990 to nonprofit institutions that need to beef up their science facilities.

But there is a catch. The applicant must already-have raised half the money it needs to replace its scientific equipment or modernize its laboratories. In addition, the program requires that twice the amount awarded then be raised from other sources as endowment for continuing support of the facility. The point is to attract more donations from corporations and individuals to help revitalize the science infrastructure, says John E. Marshall Ill, Kresge ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies